Westminster, MD, United States of America

John A Bonck

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of John A. Bonck

Introduction

John A. Bonck is a notable inventor based in Westminster, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to drug delivery systems. His work has the potential to enhance the effectiveness of medications, making a meaningful impact on patient care.

Latest Patents

John A. Bonck holds a patent for a "Tablet for pulsed delivery." This pharmaceutical tablet comprises an immediate release portion containing an active ingredient and a delayed release portion. The delayed release portion features an enteric-coated layer, which contains either enteric-coated microparticle dosage forms or enteric-coated mini-tablet dosage forms, both containing an active ingredient. This innovative design aims to improve the delivery and efficacy of medications.

Career Highlights

John A. Bonck is currently employed at Shionogi, Inc., where he continues to develop and refine pharmaceutical technologies. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in the industry. With a focus on improving patient outcomes, Bonck's work is recognized for its potential to revolutionize how medications are administered.

Collaborations

Throughout his career, John has collaborated with talented professionals, including Bruce X. Cao and Sandra E. Wassink. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical technology.

Conclusion

John A. Bonck's contributions to the field of pharmaceuticals exemplify the importance of innovation in drug delivery systems. His patent for a pulsed delivery tablet showcases his commitment to improving patient care through effective medication administration. As he continues his work at Shionogi, Inc., Bonck remains a key figure in the advancement of pharmaceutical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…